Pharmacy Times

JULY 28, 2022

Researchers highlight how a lack of access to medications used to treat multiple sclerosis, migraines, and epilepsy, but not proven safe for pregnancy, threatens child-bearing aged women who live with these conditions.

139

139

Hospital Pharmacy Europe

AUGUST 23, 2023

Atogepant is the first and only once-daily oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) approved in the European Union (EU) for the prophylaxis of migraine in adults. In the UK, draft guidance from NICE has approved another oral gepant, rimegepant, for episodic migraine. days with atogepant compared to 5.1

Hospitals 90

Hospitals 90

Pharmaceutical Technology

JUNE 1, 2023

The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of Pfizer ’s rimegepant (Vydura) to prevent migraine attacks. NICE medicines evaluation director Helen Knight said: “Each year, the lives of millions of people in England are blighted by migraine attacks.

98

98

The Checkup by Singlecare

DECEMBER 11, 2023

However, it is important to remember that headaches can occur in a variety of locations, and the location alone is not always enough to diagnose a specific condition.” Migraine headache Migraine headaches affect about 10% of the population. They can last anywhere from 30 minutes to up to a week.

105

105

STAT

JANUARY 17, 2024

Using LillyDirect, patients click into a pipeline for their condition — obesity, diabetes, or migraine — and are routed to telehealth sites that can prescribe them one of Lilly’s drugs if they’re eligible. An integration with online pharmacy Truepill will deliver the meds.

122

122

Hospital Pharmacy Europe

JUNE 2, 2023

Draft NICE guidance has approved rimegepant, a novel oral drug for preventing migraine, which it said could become available to 145,000 NHS patients. NICE said current treatments for preventing migraine – including beta-blockers, antidepressants and epilepsy medications – can have significant side effects and be ineffective.

Hospitals 98

Hospitals 98

The Checkup by Singlecare

JANUARY 11, 2024

Key takeaways | Drug interactions | Food interactions | Other interactions | Avoiding interactions | When to see a doctor Sumatriptan , marketed under the brand name Imitrex, is a triptan approved by the Food and Drug Administration (FDA) for treating migraines , with or without aura. It works by attaching to serotonin receptors in the brain.

Compounding 52

Compounding Dosage FDA 52

The Checkup by Singlecare

MARCH 17, 2023

Food and Drug Administration approved Zavzpret, the first calcitonin gene-related peptide (CGRP) antagonist nasal spray to treat acute migraine (with or without aura) in adults. who experience migraine. A migraine treatment taken by mouth has to be broken down in the digestive system before it enters the bloodstream. In the U.S.

FDA 98

FDA Insurance Coverage Insurance 98

European Pharmaceutical Review

APRIL 20, 2023

Participants with episodic migraines who have had no success with other preventive drugs had an average of four fewer days with migraine per month when given oral atogepant. CGRP is a protein that plays a key role in starting the migraine process. The other half of the participants took a placebo for 12 weeks.

Hospitals 88

Hospitals 88

Pharmacy Times

JUNE 13, 2023

More than ever, patients are turning to OTC products to treat conditions like allergies, arthritis, coughs, colds, migraines, and gastrointestinal issues.

65

65

The Checkup by Singlecare

DECEMBER 26, 2023

Eyebrow pain can be associated with various conditions, such as inflamed sinuses or migraine, among others. Eyebrow headaches due to sinus infections may be temporary, while eyebrow headaches caused by an underlying medical condition may recur. Have you ever felt pain specifically around or behind one or both eyebrows?

Immunization 52

Immunization Vaccines 52

The Checkup by Singlecare

NOVEMBER 18, 2022

Before the first migraine-specific drugs hit the pharmaceutical market in 2018, the medications used to treat migraine were meant for other health conditions. Antidepressants, beta blockers, and epilepsy drugs reduced migraine symptoms in many people, but no one knew for sure how or why. Here’s what you need to know.

98

98

Hospital Pharmacy Europe

SEPTEMBER 14, 2023

NICE has approved rimegepant (brand name Vydura) as the first treatment for acute migraine, in draft guidance published today (14 September). It prevents the release of calcitonin gene-related peptide thought to be responsible for the severe pain associated with migraine attacks. NICE put the cost of the drug at £12.90

Hospitals 59

Hospitals 59

The Checkup by Singlecare

DECEMBER 13, 2023

Headaches confined to a specific location can be a sign of certain conditions or head injuries, says Nishant Reddy, MD , an ear, nose, and throat specialist at NJ ENT in Marlton, New Jersey. Cluster headaches and migraines tend to cause severe pain on just one side of your head, while sinus headaches can develop on one or both sides.

Hospitals 52

Hospitals 52

The Checkup by Singlecare

DECEMBER 27, 2023

In fact, a lack of sleep is a known trigger for migraine and other types of headaches, too. Research suggests that poor sleep quality directly affects the severity and frequency of migraine and tension headaches. This disruption can lead to certain types of headaches, including migraines and cluster headaches.

59

59

The Checkup by Singlecare

JANUARY 18, 2024

A heavy head may also be due to an illness or medical condition, like a sinus condition or migraine headache. Less commonly, a heavy head may be a sign of a more serious condition, such as a brain tumor. Not sleeping enough —or even sleeping too much to make up for lost sleep—can cause migraines.

Chemotherapy 52

Chemotherapy Hospitals 52

The Checkup by Singlecare

APRIL 11, 2024

only half of people with migraines have seen a healthcare provider for their headaches in the past year, and only two-thirds have been diagnosed correctly, per the WHO. Primary headache disorders have no other cause, while secondary headaches can be attributed to another condition or cause, and the headache is just a symptom.

52

52

STAT

JULY 3, 2023

Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis, or obesity — their physician will offer a new kind of treatment plan that involves both pharmaceutical-based medication and a prescription digital therapeutic.

78

78

The Checkup by Singlecare

JANUARY 2, 2024

For others, dehydration is a very common trigger for migraine headaches , which are one-sided, severe, throbbing headaches with nausea and sensitivity to light and sound.” Rarely, if you drink too much water too fast, it can cause a condition called water intoxication, or water toxicity, which can be dangerous.

105

105

Pharmaceutical Technology

APRIL 26, 2023

Click Therapeutics announced the initiation of a fully remote trial investigating the potential of digital therapeutics to reduce migraine occurrences in adults diagnosed with episodic migraines. The ReMMi-D Phase III trial is expected to enroll approximately 558 participants in the US.

FDA 52

FDA 52

pharmaphorum

JUNE 22, 2022

AbbVie has filed for approval of its oral CGRP inhibitor Qulipta for prevention of chronic migraine, seeking to leap ahead of its main rival in the class. Chronic migraine is defined as having at least 15 migraine days per month for at least three months, while episodic migraine covers people with between zero and 14 migraine days per month.

Labelling 68

Labelling FDA 68

The Checkup by Singlecare

DECEMBER 27, 2023

Migraines can be debilitating, and they affect more than 1 billion people globally. Fioricet ( butalbital-APAP-caffeine ) is a combination medication used to treat tension headaches, but it may also be prescribed for migraines. How does Fioricet treat migraine headaches? Caffeine is a natural CNS stimulant that boosts alertness.

Mayo Clinic 52

Mayo Clinic Dosage FDA 52

The Checkup by Singlecare

AUGUST 23, 2023

| How to get Nurtec without insurance Nurtec ODT (orally disintegrating tablet) is a brand-name prescription drug that helps prevent migraine headaches or relieve the symptoms of a migraine episode. All of these contribute to migraine symptoms. People take Nurtec at the onset of a migraine headache for symptom relief.

Insurance 52

Insurance Insurance Coverage FDA 52

Hospital Pharmacy Europe

NOVEMBER 1, 2022

Since 2006, he has been working on migraine and, in particular, experimental models of migraine. We had the pleasure of speaking with Professor Ashina about his work, some of the innovations in patient management and his hopes for the future for helping sufferers of this debilitating condition. How is migraine classified?

Communication 52

Communication Hospitals 52

The Checkup by Singlecare

DECEMBER 27, 2023

Common causes of a headache on top of the head include tension, nerve inflammation, migraine, and dehydration. Migraine headaches Migraine is a headache disorder that causes moderate to severe pain. For example, a headache on the top of the head often feels like a heavy weight or a tightness on or around the top of the skull.

Mayo Clinic 52

Mayo Clinic 52

The Guardian - Pharmaceutical Industry

SEPTEMBER 26, 2022

The health minister, Mark Butler, on Monday announced Australians will have expanded access to some medicines from 1 October, saving $130m a year in out-of-pocket costs.

77

77

Hospital Pharmacy Europe

DECEMBER 19, 2022

The presence of enlarged perivascular spaces in the brains of migraine patients may indicate the presence of glymphatic disruption. Migraine is a common headache-related condition that affects an estimated 12% of the population. Enlarged perivascular spaces in migraine and control patients.

Hospitals 52

Hospitals 52

The Checkup by Singlecare

DECEMBER 26, 2023

Headaches on the right side of the head can be caused by muscle tension, migraine, sinus inflammation, and more. They can be remedied by over-the-counter (OTC) painkillers, prescription migraine medication, stretching, or hot or cold compresses. Typically, migraine causes throbbing pain on the left or right side of the head.

52

52

pharmaphorum

FEBRUARY 11, 2022

The new company has emerged onto the scene with $57 million in new funding from tech investor Francisco Partners – backed by the American Medical Association’s venture capital arm Health 2047, Kirkland & Ellis and Twofold Ventures – and a mobile app product for people with migraine. Matt Scantland.

52

52

Druggist

JANUARY 9, 2021

Migraine is a common condition affecting an estimated 6 million people in the UK. With approximate 190,000 migraine attacks experienced by people in the UK (NICE, 2012), pharmacies are among the first points of call to find over the counter migraine medication. What is the best painkiller for migraine? Paracetamol.

Packaging 98

Packaging 98

pharmaphorum

NOVEMBER 18, 2020

UK cost-effectiveness agency NICE has said that Eli Lilly’s Emgality can be made available through the NHS for migraine prevention, the second drug in the CGRP inhibitor class to achieve that milestone.

90

90

PharmaShots

JUNE 22, 2023

The results showed no statistical difference b/w women with migraine who used the device during pregnancy throughout 3mos. The device is a safe treatment for migraine during pregnancy, not increasing the risk for adverse pregnancy outcomes. postpartum, and for those who did not use during this period, 66.7% achieved pain relief @2hrs.

40

40

The Checkup by Singlecare

JANUARY 18, 2024

There are three types of primary headache disorders : migraine, tension-type headache (TTH), and cluster headache (CH). Migraine headaches often occur on one side of the head and are a pulsating type of pain. Exercise Exercise has been shown to benefit inflammatory and vascular conditions such as headaches and migraines.

52

52

Hospital Pharmacy Europe

SEPTEMBER 8, 2022

Results of two studies presented at the Migraine Trust International Symposium (MTIS) in London, UK, demonstrate the efficacy of fremanezumab in migraine patients who also experience depression or anxiety. . 1,2 This is an important outcome because psychiatric disorders are a common comorbidity in patients suffering from migraine.

Hospitals 52

Hospitals 52

pharmaphorum

NOVEMBER 18, 2020

UK cost-effectiveness agency NICE has said that Eli Lilly’s Emgality can be made available through the NHS for migraine prevention, the second drug in the CGRP inhibitor class to achieve that milestone.

86

86

pharmaphorum

JULY 18, 2022

AbbVie has submitted its oral CGRP inhibitor atogepant for prevention of both episodic and chronic migraine in the EU as it tries to catch up with main rivals Pfizer/BioHaven and their recently-approved Vydura drug. GlobalData has said it expects Qulipta to get approval for chronic migraine prevention in 2023, helping it to sales of $1.2

FDA 52

FDA 52

STAT

DECEMBER 5, 2022

Its approach has been to build multiple “storefronts” that allow users to access providers who can prescribe medications and deliver follow-up care for different conditions: Keeps for hair loss, Picnic for allergies, Cove for migraine, and more.

86

86